[Whole abdomino-pelvic moving strip irradiation in ovarian cancer].
From 1982 to 1987, 45 patients with ovarian cancer (21 Stage I, 8 Stage II, 5 Stage III-IV and 11 recurrent or metastatic lesions) were treated in our hospital. All received postoperative 60Co whole abdomino-pelvic moving strip irradiation. Tumor dose ranged from 20 to 26 Gy, in addition, a booster dose of 10-20 Gy was given to the pelvis. Serious gastrointestinal reaction and myelosuppression were rare, and no radio-nephritis or hepatitis was found. The 1, 3 and 5 year survival rates were 100%, 92% and 83% for Stage I; 100%, 100% and 100% for Stage II; 100%, 66.7% and 66.7% for Stage III-IV and 100%, 50% and 20% for recurrent or metastatic lesions, respectively. The author believes that the whole abdomino-pelvic moving strip irradiation is only indicated for patients with dysgerminoma, granulosa cell tumor and resected adenocarcinoma without residual tumor or with residual tumor smaller than 0.5 cm in diameter in the abdomen or smaller than 2 cm in the pelvis. The causes of treatment failure are discussed.
Lou
H K
HK
Zhejiang Cancer Hospital, Hangzhou.
D000293:Adolescent; D000328:Adult; D002648:Child; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D004407:Dysgerminoma / Q000401:mortality / Q000532:radiotherapy*; D005260:Female; D005500:Follow-Up Studies; D006106:Granulosa Cell Tumor / Q000000981:diagnostic imaging* / Q000401:mortality; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D011184:Postoperative Period; D011859:Radiography; D011867:Radioisotope Teletherapy / Q000379:methods; D015996:Survival Rate
D003037:Cobalt Radioisotopes